Corrigendum to "Ginsenoside Rb1 attenuates methamphetamine (METH)-induced neurotoxicity through the NR2B/ERK/CREB/BDNF signalings in vitro and in vivo models"

• Genmeng, Yang (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Juan, Li (School of Basic Medicine, Kunming Medical University) ;
• Yanxia, Peng (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Baoyu, Shen (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Yuanyuan, Li (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Liu, Liu (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Chan, Wang (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Yue, Xu (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Shucheng, Lin (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Shuwei, Zhang (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Yi, Tan (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Huijie, Zhang (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Xiaofeng, Zeng (NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University) ;
• Qi, Li (SDIVF R&D Centre) ;
• Gang, Lu (CUHK-SDU Joint Laboratory on Reproductive Genetics, School of Biomedical Sciences, the Chinese University of Hong Kong)

• Published : 2023.03.02

• https://doi.org/10.1016/j.jgr.2023.01.001 Copy Citation PDF